(Q34376119)

1 August 2017

1 reference

title

Peptide aptamers: new tools to study protein interactions (English)

1 reference

1 August 2017

Hoppe-Seyler F

1

1 reference

1 August 2017

Crnkovic-Mertens I

2

1 reference

1 August 2017

Denk C

3

1 reference

1 August 2017

Fitscher BA

4

1 reference

1 August 2017

Klevenz B

5

1 reference

1 August 2017

Tomai E

6

1 reference

1 August 2017

Butz K

7

1 reference

1 August 2017

publication date

1 August 2001

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

1 August 2017

published in

1 reference

1 August 2017

volume

78

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

105-111

1 reference

A novel genetic system to detect protein-protein interactions

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Tag games in yeast: the two-hybrid system and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

The impact of two-hybrid and related methods on biotechnology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Selection of antibodies for intracellular function using a two-hybrid in vivo system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

The selection of intracellular antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

The two-hybrid system: an assay for protein-protein interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Protein-peptide interactions analyzed with the yeast two-hybrid system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Constrained peptides as binding entities

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Structural and mechanistic determinants of affinity and specificity of ligands discovered or engineered by phage display

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Genetic selection of peptide inhibitors of biological pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

An artificial cell-cycle inhibitor isolated from a combinatorial library

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Tendamistat as a scaffold for conformationally constrained phage peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Selection of peptides that functionally replace a zinc finger in the Sp1 transcription factor by using a yeast combinatorial library

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Green fluorescent protein as a scaffold for intracellular presentation of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Transdominant genetic analysis of a growth control pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

"Mutagenesis" by peptide aptamers identifies genetic network members and pathway connections

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Dominant effector genetics in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Targeting cyclin-dependent kinases in Drosophila with peptide aptamers.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Clinical aspects of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

1 reference

7 January 2021

Isolation of peptide aptamers that inhibit intracellular processes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Recent developments in structure-based drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Protease inhibitors: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Improving protein therapeutics with sustained-release formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Therapeutic peptides revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900085-1

7 January 2021

10.1016/S0960-0760(01)00085-1

Identifiers

DOI

1 reference

1 August 2017

1 reference